Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY: LLY )

206.14 USD +3.79 (+1.87%)
Official Closing Price Updated: 7:58 PM EST, Jan 22, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Stories about Eli Lilly

< Previous 1 2
...
93 94 95 96 97 98 99 100 Next >
7 Biotech Catalysts Remaining In January
Biotech stocks are regaining some lost momentum after Wednesday's Trump-inspired selloff that took a toll on the sentiment on pharma ... 
Tags Benzinga Events baricitinib
From Benzinga
Trump's 'Disastrous' Pharma View Doesn't Rattle JPMorgan Drug Conference
What should investors take away from the JPMorgan Healthcare Conference? Despite drug-pricing woes, sentiment is "cautiously optimistic." 
Tags Technology
From Investor's Business Daily
Watch These 5 Huge Put Purchases In Friday Trade
Benzinga's newsdesk monitors options activity to notice unusual patterns. These large volume (and often out of the money) trades ... 
Tags FCAU Options RESI
From Benzinga
Investors in big pharma, biotech look to ride out Trump storm
NEW YORK, Jan 12 (Reuters) - Investors in large U.S. pharmaceutical and biotech companies are counting on strong dividends, reasonable stock valuations and new products to help ride out a storm of... 
Tags companyNews
From Reuters: Company News
Pharma company executives debate drug pricing increases
SAN FRANCISCO Jan 12 (Reuters) - Grappling with a backlash against high U.S. prescription drug prices, more pharmaceutical companies are pledging to limit annual increases to under 10 percent - but the... 
Tags companyNews
From Reuters: Company News
Eli Lilly Rebounds On Chemo-Drug Patent Win Vs. Generic Teva
Lilly stock bounded Thursday after a federal appellate court upheld the patent on chemo Alimta vs. drugmaker Teva. 
Tags Technology
From Investor's Business Daily
Teva 'Disappointed' In Court's Patent Decision
In the latest development in the court battle between Eli Lilly And Co (NYSE: LLY) and Teva Pharmaceutical Industries Ltd (ADR) ... 
Tags Alimta Benzinga Legal
From Benzinga
Teva loses appeal against Eli Lilly in Alimta patent case
Jan 12 (Reuters) - A U.S. appeals court on Thursday ruled in favor of Eli Lilly & Co in a closely-watched patent case, saying a lower court judge correctly found Teva Pharmaceutical Industries Ltd and... 
Tags companyNews
From Reuters: Company News
BRIEF-U.S. appeals court rejects Teva appeal in Lilly patent case over Alimta
Jan 12 (Reuters) - U.S. Appeals Court rules for Eli Lilly and against Teva Pharmaceutical in Alimta patent case -- court ruling 
Tags companyNews
From Reuters: Company News
3 Surprises From Pfizer at the J. P. Morgan Healthcare Conference
Tags LLY NVS PFE
From Motley Fool
What pharma investors ought to do after Donald Trump fires a salvo
Reduce exposure to those industries on fears of a drug-price crackdown, says Nigam Arora. 
Tags JNJ XBI Medical Products
From MarketWatch
BRIEF-Eli Lilly and Merck expand immuno-oncology collaboration
* Eli Lilly and co - financial details of collaboration were not disclosed. 
Tags companyNews
From Reuters: Company News
Incyte's Prospects Get Even Brighter With Merck Announcement
Tags INCY MRK LLY
From Motley Fool
This Could Very Well Be the Greatest Drug Advancement in a Decade
Tags BIIB LLY
From Motley Fool
Why Aratana Therapeutics Inc. Rocketed 42.7% Higher in 2016
Tags PETX LLY
From Motley Fool
Five unpopular, but prudent, things for investors to do near Dow 20,000
It’s time to sell over-owned stocks and trim some others, says Nigam Arora. 
Tags MRK Opinion SPY
From MarketWatch
The MedTech Group: 2017 Top Picks And Catalysts
Over the past year, the gap between MedTech stocks and the S&P index has narrowed significantly, and these are currently trading ... 
Tags ABMD EXAS ONVO
From Benzinga
2 Big Reasons Merck & Co., Inc. Stock Surged 11% in 2016
Tags BMY MRK LLY
From Motley Fool
BRIEF-Lilly to adjust organization and leadership structure to better align with growth opportunities
* Lilly to adjust organization and leadership structure to better align with growth opportunities 
Tags companyNews
From Reuters: Company News
BRIEF-U.S. FDA approves supplemental New Drug Applications for three Type 2 diabetes medicines
* U.S. FDA approves supplemental new drug applications to include landmark data in product labels for synjardy (empagliflozin/metformin hydrochloride), synjardy xr (empagliflozin/metformin... 
Tags companyNews
From Reuters: Company News
Lilly Nears FDA Nod On Arthritis Drug, But Chemo Med Stuck In Court
Drugmaker Eli Lilly will likely add a rheumatoid arthritis drug to its FDA-approved repertoire this month, Credit Suisse says. 
Tags Technology
From Investor's Business Daily
My Worst Predictions for Biotech in 2016
Tags XPH VRX PFE
From Motley Fool
Two Key FDA Decisions To Watch Out For In January 2017
Several drug companies could see regulatory milestones passed in January 2017. Here's a look at a couple of important regulatory events scheduled for this month. 
Tags Pharma/Biotech Stocks / Equities
From Blogs - TalkMarkets
Amgen Plans Robust 2017 In Alzheimer's, Migraines, Oncology: CEO Exclusive
Amgen expects to compete robustly in the anti-CGRP migraine market vs. Alder BioPharma, Teva Pharmaceutical and Eli Lilly. 
Tags Technology
From Investor's Business Daily
In the age of Uber and Lyft, it’s still hard for some Americans to get to the doctor
When a researcher first started looking at high diabetes rates among Bangladeshi Americans, transportation was the heart of the problem. 
Tags Personal Finance Retail SPX
From MarketWatch
Johnson & Johnson's 4 Biggest Catalysts in 2017
Tags ABBV LLY JNJ
From Motley Fool
UPDATE 1-U.S. FTC requires divestitures in $13.53 bln Boehringer-Sanofi deal
WASHINGTON, Dec 28 (Reuters) - German pharmaceutical company Boehringer Ingelheim agreed to divest five types of animal health products to settle charges that a proposed asset swap with Sanofi would... 
Tags companyNews
From Reuters: Company News
A Preview Of January PDUFA Dates
Biopharma companies did not have much to write home about in the year 2016, as negative news flow on price gouging hit many stocks in ... 
Tags plecanatide Biotech VCEL
From Benzinga
VTV, USB, LLY, LMT: ETF Inflow Alert
Symbols mentioned in this story: VTV, USB, LLY, LMT Exchange traded funds (ETFs) trade just like stocks, but instead of ''shares'' investors are actually buying and selling ''units''. These ''units''... 
Tags ETFs
From ETF Channel
Expect Availability Of Biogen's Newly Approved Spinraza In Just One Week
Biogen Inc (NASDAQ: BIIB) said its newly approved Spinraza (nusinersen) would be available in just one week time. Spinraza is approved ... 
Tags CLVS FDA Trading Ideas
From Benzinga
< Previous 1 2
...
93 94 95 96 97 98 99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.